PEAK6 Investments’s Twist Bioscience TWST Stock Holding History

PEAK6 Investments’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$678K	Sell	15,000 -2,500	-14%	-$119K	﹤0.01%	2138
2024 Q2	$862K	Buy	17,500 +3,500	+25%	+$143K	﹤0.01%	1937
2024 Q1	$480K	Buy	+14,000	New	+$505K	﹤0.01%	2473
2022 Q3	–	Sell	-14,501	Closed	-$507K	–	6155
2022 Q2	$507K	Sell	14,501 -12,681	-47%	-$449K	﹤0.01%	3812
2022 Q1	$1.34M	Buy	27,182 +16,094	+145%	+$892K	﹤0.01%	2211
2021 Q4	$858K	Buy	+11,088	New	+$1.14M	﹤0.01%	2693

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Investments's TWST Position: Q3 2024 in Review

PEAK6 Investments reduced its Twist Bioscience (TWST) stake by 14% in Q3 2024, selling an estimated $119K and leaving 15,000 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

PEAK6 Investments first reported a position in TWST in Q4 2021 and has held it in 6 quarters since. The position peaked at $1.34M in Q1 2022. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

PEAK6 Investments held 15,000 shares of Twist Bioscience worth $678K as of Q3 2024.
PEAK6 Investments sold 2,500 Twist Bioscience shares in Q3 2024, an estimated $119K.
Twist Bioscience made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2138 holding.
PEAK6 Investments first reported a position in Twist Bioscience in Q4 2021 and has held it in 6 quarters since.
PEAK6 Investments's Twist Bioscience position peaked at $1.34M in Q1 2022.
245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.